LEVATOL Drug Patent Profile
✉ Email this page to a colleague
When do Levatol patents expire, and what generic alternatives are available?
Levatol is a drug marketed by Auxilium Pharms Llc and is included in one NDA.
The generic ingredient in LEVATOL is penbutolol sulfate. There are two drug master file entries for this compound. Additional details are available on the penbutolol sulfate profile page.
Summary for LEVATOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 5,336 |
DailyMed Link: | LEVATOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LEVATOL
US Patents and Regulatory Information for LEVATOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Auxilium Pharms Llc | LEVATOL | penbutolol sulfate | TABLET;ORAL | 018976-001 | Dec 30, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Auxilium Pharms Llc | LEVATOL | penbutolol sulfate | TABLET;ORAL | 018976-004 | Jan 5, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |